Strategic Partnerships Surfacide has a track record of strategic collaborations with large healthcare and facility operators (e.g., MedStar Health) and expanded partnerships (PathTrac) in clinical and operational settings, indicating ripe opportunities for expansion via system integrations and joint ventures with hospitals and OR managers.

Expansion Ready Programs Recent program launches such as SURFrx, GLŌ PX, and Eos indicate a portfolio approach to UV-C disinfection across hospital, pharmacy, and high-traffic spaces, suggesting cross-selling opportunities to facilities seeking comprehensive disinfection solutions and portable options.

Government & Public Sector Existing government contracting exposure through Fidelis Sustainability Distribution and ECAT contracts points to a pathway for targeting public hospitals, large health systems, and federal facilities with prefabricated procurement channels and defined contract vehicles.

Clinical Efficacy Emphasis With over 600 deployments and a focus on hospital-grade, evidence-based disinfection, there is strong credibility to approach infection prevention, environmental services, and senior leadership teams with ROI-driven use cases and log reductions in environmental bioburden.

Global Deployment Signals A broad installed base across hospitals, long-term care communities, and public venues demonstrates scalable implementation capabilities and potential for multi-site deals, managed service arrangements, or enterprise-wide rollouts.